共查询到20条相似文献,搜索用时 225 毫秒
1.
通过分子克隆技术将Sufu和SAP18构建到原核载体,在原核表达系统进行外源表达,采用亲和层析和分子筛层析对Sufu和SAP18及其复合物进行纯化。同时利用非变性胶的方法进一步确定该蛋白之间的相互作用及结合比例。结果表明,原核表达系统中Sufu和SAP18蛋白表达量高,可以纯化到高纯度的蛋白质。Sufu和SAP18结合的摩尔比为1:1,按摩尔比1:2混合、纯化可以得到高纯度、稳定的蛋白复合物,从而为进一步复合物的结构生物学研究奠定基础。 相似文献
2.
目的:克隆、表达、纯化人免疫缺陷病毒Ⅰ型(HIV-1)Vpu蛋白,为其功能及免疫学研究奠定基础。方法:PCR扩增Vpu基因,纯化、酶切后克隆到原核表达载体pET32a中,转化大肠杆菌BL21(DE3)菌株获得表达工程菌株,IPTG诱导蛋白表达,免疫印迹鉴定目的蛋白,亲和层析纯化蛋白。结果:构建了HIV-1Vpu蛋白的原核表达载体Vpu-pET32a,并在大肠杆菌中高效表达,目的蛋白呈可溶性形式存在,免疫印迹检测显示为目的蛋白,经Ni—NTAAgarose纯化获得了高纯度的目的蛋白。结论:在原核表达系统中表达了可溶性HIV-1Vpu蛋白,为进一步进行HIV-1Vpu蛋白的免疫原性和功能研究奠定了基础。 相似文献
3.
目的:原核表达重组APOBEC3G蛋白,为其功能及免疫原性研究奠定基础。方法:提取H9细胞全细胞基因组RNA,通过RT-PCR获得目的基因,经纯化、酶切后克隆到原核表达载体pET32a中,转化大肠杆菌BL21(DE3)菌株获得表达工程菌株,并对表达条件和纯化条件进行优化;利用Western Blot分析鉴定目的蛋白。结果:构建了APOBEC3G蛋白的原核表达载体Apo-His-pET32a,并在大肠杆菌中获得高表达,目的蛋白以可溶性蛋白形式存在;经Ni-NTA亲和层析柱一步纯化,获得了高纯度的重组APOBEC3G蛋白,蛋白浓度可达1.2mg/mL;Westem Blot显示获得了目的蛋白。结论:在原核表达系统中表达、纯化了可溶性APOBEC3G蛋白,为进一步对其进行免疫原性和功能研究奠定了基础。 相似文献
4.
目的:构建人Hepassocin的原核表达载体,可溶性表达并纯化得到高纯度的重组人Hepassocino方法:将人Hepassocin基因克隆到原核表达载体pET40b(+),转化大肠杆菌BL21(DE3),于28℃经0.1mmol/LIPTG诱导6h,表达Ds-bC-Hepassocin融合蛋白,经镍柱纯化可溶性融合蛋白,用肠激酶切除融合蛋白的DsbC-His标签,再用镍柱纯化分离酶切后的Hepassocin,通过超滤进一步纯化并浓缩,用Western blot验证纯化后的Hepassocin。结果:构建了pET40b-Hepassocin原核表达载体,经诱导表达、亲和层析和肠激酶切除融合标签,获得了相对分子质量约32000的可溶性高纯度蛋白,Western blot鉴定证实该蛋白为不含融合标签的重组人Hepassocin。结论:实现了人Hepassocin的原核可溶性表达,通过纯化获得了较高纯度的重组人Hepassocin,为制备其单克隆抗体,进一步研究其生物学功能奠定了基础。 相似文献
5.
目的:构建炭疽芽胞杆菌FtsE蛋白的原核表达载体,实现其在原核表达系统中的可溶性表达,并纯化融合蛋白。方法:用PCR方法从炭疽芽胞杆菌A16R株扩增得到厅sE基因片段,酶切后连接到pET28a原核表达载体,构建重组表达质粒pET28a-ftsE,转化大肠杆菌BL21(DE3)菌株,筛选可溶性诱导表达与纯化融合蛋白的条件,以获得高纯度融合蛋白。结果:构建了FtsE蛋白的融合表达载体,并在大肠杆菌中获得高效表达;在20℃下,经0.1mmol/LIPTG诱导3h表达的产物主要是可溶性蛋白,经Ni-NTA亲和层析纯化获得了高纯度的FtsE融合蛋白,经Western印迹检测,目的蛋白表达正确。结论:实现了炭疽芽胞杆菌FtsE蛋白原核表达系统的可溶性表达并获得了高纯度融合蛋白,为后续研究奠定了基础。 相似文献
6.
弗氏2a志贺氏菌2457T株YciD蛋白的融合表达和纯化 总被引:2,自引:0,他引:2
目的:原核表达重组弗氏2a志贺氏菌2457T株YciD蛋白,为其功能研究奠定基础。方法:用PCR方法从弗氏2a志贺氏菌2457T株染色体中扩增YciD蛋白编码序列,经过纯化、酶切后克隆到原核表达载体pET32a中,构建重组载体pET32a-yciD,转化大肠杆菌BL21(DE3)菌株获得工程菌株,对其表达和纯化条件进行优化;利用Western Blot检测融合蛋白的表达。结果:构建了YciD蛋白的融合表达载体,并在大肠杆菌中获得高效表达;经Ni-NTA亲和层析柱纯化获得了高纯度的YciD蛋白;Western Blot表明,此蛋白可与His标签抗体反应,表明获得了目的蛋白。结论:在原核表达系统中表达、纯化弗氏2a志贺氏菌2457T株YciD蛋白,为进一步对其进行功能研究奠定了基础。 相似文献
7.
《生物技术通讯》2020,(3)
目的:利用原核系统对新型冠状病毒S蛋白的受体结合域(RBD)肽段进行克隆、表达和纯化,制备高纯度的RBD肽。方法:在RBD肽段N端加入肠激酶位点序列(DDDDK),对应的核酸序列参照原核系统表达偏好进行全基因合成,构建pET-DsbC-RBD融合表达载体,通过原核表达和亲和纯化获得DsbC-RBD融合蛋白,用肠激酶对融合蛋白进行酶切和二次亲和纯化,获得高纯度新冠病毒S蛋白RBD肽。结果:构建了pET-DsbC-RBD表达载体,融合蛋白DsbC-RBD在大肠杆菌中实现了高效表达,经亲和层析纯化,重组融合蛋白DsbC-RBD相对分子质量为58×103,纯度约90%。用肠激酶对融合蛋白进行酶切,酶切效率近100%,通过二次亲和纯化获得了RBD肽,相对分子质量为25×103,纯度92%以上。结论:利用原核表达系统获得可溶性DsbC-RBD融合蛋白,采用亲和纯化和肠激酶酶切联用的方法制备获得高纯度的新冠病毒S蛋白RBD肽,为后续抗体制备和抗病毒药物筛选奠定了基础。 相似文献
8.
《生物技术通讯》2020,(1)
目的:利用原核系统表达重组对人基质金属蛋白酶12(MMP-12)并纯化,获得高纯度的人MMP-12蛋白。方法:在MMP-12氨基酸序列的N端加入His标签和肠激酶位点序列,构建MMP-12融合蛋白的原核表达载体,通过表达和亲和纯化获得MMP-12融合蛋白,以肠激酶对融合蛋白进行酶切和二次纯化,获得高纯度的人MMP-12。结果:构建了pET-MMP-12表达载体,并在大肠杆菌中实现了稳定高效表达。重组融合蛋白MMP-12经亲和层析纯化后,相对分子质量为42×10~3,纯度约95%。利用肠激酶对融合蛋白MMP-12进行酶切,酶切效率接近100%,通过二次纯化获得了MMP-12,相对分子质量为40.8×10~3,纯度大于95%。结论:利用原核表达系统高效表达了MMP-12融合蛋白,通过亲和纯化和肠激酶酶切的方法可以获得高纯度的MMP-12,为后续抗体制备和配基筛选奠定了基础。 相似文献
9.
炭疽芽孢杆菌EA1蛋白的融合表达和纯化 总被引:1,自引:0,他引:1
目的:原核表达重组炭疽芽孢杆菌EA1蛋白。方法:用PCR方法从炭疽芽孢杆菌A16R疫苗株染色体中扩增编码EA1蛋白的eag基因序列,经过纯化、酶切后克隆到含有GST标签的原核表达载体pGEX-6P-2中,构建重组载体pGEX-EA1;将空载体(作为对照)、重组载体转化大肠杆菌BL21(DE3)菌株获得表达工程菌株,对其表达和纯化条件进行优化;利用Western印迹检测融合蛋白的表达。结果:构建了EA1蛋白的融合表达载体,并在大肠杆菌中获得高效表达;经Glutathione Sepharose 4B纯化获得了EA1蛋白;Western印迹表明,此蛋白可与GST标签抗体反应。结论:在原核表达系统中表达并纯化得到EA1融合蛋白,为进一步对其进行功能研究奠定了基础。 相似文献
10.
人泛素结合酶9的原核表达与纯化 总被引:1,自引:0,他引:1
目的:表达和纯化高纯度的人泛素结合酶9(hUBC9)。方法:将hUBC9基因克隆到原核表达载体pGEX-6p-1上并转化大肠杆菌BL21(DE3),于30℃、1mmol/LIPTG诱导4h,表达GST-hUBC9融合蛋白。用Glutathione-Sepharose4B柱分离GST-hUBC9融合蛋白,用鼻病毒3C蛋白水解酶切去GST-hUBC9融合蛋白的GST标签,再用FPLC分子筛层析法进一步纯化hUBC9。结果和结论:获得了重组表达质粒GST-hUBC9并在大肠杆菌中可溶性表达,经亲和层析、酶切、分子筛层析后获得了可溶的、高纯度的hUBC9,为进一步研究hUBC9的功能和结构奠定了基础。 相似文献
11.
目的构建以白念珠菌基因MP65和SAP2为目的基因的原核表达质粒,IPTG诱导其表达融合蛋白,并对其免疫原性进行分析。方法PCR法自白念珠菌标准菌株获取MP65和SAP2基因,分别插入至原核表达载体pGEx.4T之和pET32a中;将重组表达质粒转染感受态EcoliBL-21,经IPTG诱导表达、纯化后,SDS—PAGE和Western blot分析。结果PCR法克隆出全长为1140bp的MP65和1197bp的SAP2基因,构建的原核表达质粒pGEX-4T-2-MP65及pET32a-SAP2,可分别表达出66KD左右的GST融合蛋白和His融合蛋白。结论成功获取了白念珠菌基因^伊65和SAP2,所构建的原核表达质粒在BL-21中成功表达;两种蛋白均有免疫原性。 相似文献
12.
Debanu Das Robert D. Finn Polat Abdubek Tamara Astakhova Herbert L. Axelrod Constantina Bakolitsa Xiaohui Cai Dennis Carlton Connie Chen Hsiu‐Ju Chiu Michelle Chiu Thomas Clayton Marc C. Deller Lian Duan Kyle Ellrott Carol L. Farr Julie Feuerhelm Joanna C. Grant Anna Grzechnik Gye Won Han Lukasz Jaroszewski Kevin K. Jin Heath E. Klock Mark W. Knuth Piotr Kozbial S. Sri Krishna Abhinav Kumar Winnie W. Lam David Marciano Mitchell D. Miller Andrew T. Morse Edward Nigoghossian Amanda Nopakun Linda Okach Christina Puckett Ron Reyes Henry J. Tien Christine B. Trame Henry van den Bedem Dana Weekes Tiffany Wooten Qingping Xu Andrew Yeh Jiadong Zhou Keith O. Hodgson John Wooley Marc‐André Elsliger Ashley M. Deacon Adam Godzik Scott A. Lesley Ian A. Wilson 《Protein science : a publication of the Protein Society》2010,19(11):2131-2140
Sufu (Suppressor of Fused), a two‐domain protein, plays a critical role in regulating Hedgehog signaling and is conserved from flies to humans. A few bacterial Sufu‐like proteins have previously been identified based on sequence similarity to the N‐terminal domain of eukaryotic Sufu proteins, but none have been structurally or biochemically characterized and their function in bacteria is unknown. We have determined the crystal structure of a more distantly related Sufu‐like homolog, NGO1391 from Neisseria gonorrhoeae, at 1.4 Å resolution, which provides the first biophysical characterization of a bacterial Sufu‐like protein. The structure revealed a striking similarity to the N‐terminal domain of human Sufu (r.m.s.d. of 2.6 Å over 93% of the NGO1391 protein), despite an extremely low sequence identity of ~15%. Subsequent sequence analysis revealed that NGO1391 defines a new subset of smaller, Sufu‐like proteins that are present in ~200 bacterial species and has resulted in expansion of the SUFU (PF05076) family in Pfam. 相似文献
13.
Role of the Sin3-Histone Deacetylase Complex in Growth Regulation by the Candidate Tumor Suppressor p33ING1 总被引:14,自引:0,他引:14
下载免费PDF全文
![点击此处可从《Molecular and cellular biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A. Kuzmichev Y. Zhang H. Erdjument-Bromage P. Tempst D. Reinberg 《Molecular and cellular biology》2002,22(3):835-848
Sin3 is an evolutionarily conserved corepressor that exists in different complexes with the histone deacetylases HDAC1 and HDAC2. Sin3-HDAC complexes are believed to deacetylate nucleosomes in the vicinity of Sin3-regulated promoters, resulting in a repressed chromatin structure. We have previously found that a human Sin3-HDAC complex includes HDAC1 and HDAC2, the histone-binding proteins RbAp46 and RbAp48, and two novel polypeptides SAP30 and SAP18. SAP30 is a specific component of Sin3 complexes since it is absent in other HDAC1/2-containing complexes such as NuRD. SAP30 mediates interactions with different polypeptides providing specificity to Sin3 complexes. We have identified p33ING1b, a negative growth regulator involved in the p53 pathway, as a SAP30-associated protein. Two distinct Sin3-p33ING1b-containing complexes were isolated, one of which associates with the subunits of the Brg1-based Swi/Snf chromatin remodeling complex. The N terminus of p33ING1b, which is divergent among a family of ING1 polypeptides, associates with the Sin3 complex through direct interaction with SAP30. The N-terminal domain of p33 is present in several uncharacterized human proteins. We show that overexpression of p33ING1b suppresses cell growth in a manner dependent on the intact Sin3-HDAC-interacting domain. 相似文献
14.
Singh KK Erkelenz S Rattay S Dehof AK Hildebrandt A Schulze-Osthoff K Schaal H Schwerk C 《RNA (New York, N.Y.)》2010,16(12):2442-2454
RNPS1, Acinus, and SAP18 form the apoptosis- and splicing-associated protein (ASAP) complex, which is also part of the exon junction complex. Whereas RNPS1 was originally identified as a general activator of mRNA processing, all three proteins have been found within functional spliceosomes. Both RNPS1 and Acinus contain typical motifs of splicing regulatory proteins including arginine/serine-rich domains. Due to the absence of such structural features, however, a function of SAP18 in splicing regulation is completely unknown. Here we have investigated splicing regulatory activities of the ASAP components. Whereas a full-length Acinus isoform displayed only limited splicing regulatory activity, both RNPS1 and, surprisingly, SAP18 strongly modulated splicing regulation. Detailed mutational analysis and three-dimensional modeling data revealed that the ubiquitin-like fold of SAP18 was required for efficient splicing regulatory activity. Coimmunoprecipitation and immunofluorescence experiments demonstrated that SAP18 assembles a nuclear speckle-localized splicing regulatory multiprotein complex including RNPS1 and Acinus via its ubiquitin-like fold. Our results therefore suggest a novel function of SAP18 in splicing regulation. 相似文献
15.
目的:原核表达系统表达人乳头瘤病毒18型(HPV18)L1蛋白,建立包涵体和可溶性表达的L1蛋白的纯化方法。方法:构建重组表达质粒p GEX-4T-1-HPV18 L1,在大肠杆菌BL21中以包涵体和可溶性方式表达HPV18 L1蛋白。通过超声波破碎菌体、洗涤包涵体、碱变性、透析复性和谷胱甘肽(GST)琼脂糖凝胶4B亲和层析纯化包涵体蛋白;在菌体中加入三磷酸腺苷(ATP)和3.5 mol/L尿素孵育后,GST 4B亲和层析纯化可溶性蛋白,凝血酶酶切。SDS-PAGE和Western印迹鉴定表达和纯化产物。结果:SDS-PAGE结果表明,HPV18 L1蛋白以包涵体和可溶性方式在大肠杆菌BL21内高效表达,均产生相对分子质量约为86 000的HPV18 L1-GST融合蛋白。Western印迹结果显示,包涵体纯化后获得的融合蛋白降解条带较多;而可溶性蛋白纯化后获得的融合蛋白未降解,凝血酶酶切后得到HPV18 L1蛋白,可与HPV18 L1蛋白单克隆抗体结合。结论:采用原核系统表达了HPV18 L1-GST融合蛋白,分别建立了包涵体和可溶性蛋白的纯化方法,获得HPV18 L1蛋白,为其进一步应用奠定了基础。 相似文献
16.
为了探讨人偏肺病毒(hMPV)融合蛋白(F)在原核表达系统中的表达效果及其应用价值,用大肠杆菌表达系统表达hMPV F1亚单位蛋白并用镍柱(Ni-NTA)进行亲和层析纯化,并以其为抗原,用Western Blot方法进行人血清抗体检测的探索。根据F蛋白的疏水性、抗原位点和表面可及性的预测结果选择F1亚单位为目标区域,在大肠杆菌BL21中分别得到了带有6个组氨酸(His)标记的不同基因型hMPV的F1亚单位蛋白的高效表达,目的蛋白大小约37.0 kD,主要以包涵体形式存在。Western Blot检测显示表达的目的蛋白可以特异性地结合抗hMPV的豚鼠多克隆抗体以及确定为hMPV急性感染患者的血清,而且与副粘病毒科肺病毒属的呼吸道合胞病毒(RSV)和副流感病毒(PIV)(2和3型)之间没有交叉反应,显示表达的F1蛋白的特异性和抗原性良好。应用该表达蛋白进行部分人群血清抗体检测的探索,结果显示人群血清抗hMPV-F蛋白的IgG抗体总阳性率约为66%~67%,0~2岁组的血清抗体阳性率随年龄增长呈现逐渐下降趋势,新生儿的抗体阳性率最高,达85%左右,>1岁~2岁组幼儿阳性率最低,提示母传抗体的存在。随后各年龄组人群随年龄的增长血清抗体阳性率逐渐增高,>60岁年龄组人群抗体水平最高,上述结果提示<2岁儿童为hMPV的易感人群。 相似文献
17.
18.
Modulation of YY1 activity by SAP30 总被引:3,自引:0,他引:3
Huang NE Lin CH Lin YS Yu WC 《Biochemical and biophysical research communications》2003,306(1):267-275
19.
Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core 总被引:8,自引:2,他引:6
下载免费PDF全文
![点击此处可从《RNA (New York, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The multiprotein exon junction complex (EJC) is deposited on mRNAs upstream of exon-exon junctions as a consequence of pre-mRNA splicing. In mammalian cells, this complex serves as a key modulator of spliced mRNA metabolism. To date, neither the complete composition nor the exact assembly pathway of the EJC has been entirely elucidated. Using in vitro splicing and a two-step chromatography procedure, we have purified the EJC and analyzed its components by mass spectrometry. In addition to finding most of the known EJC factors, we identified two novel EJC components, Acinus and SAP18. Heterokaryon analysis revealed that SAP18 is a shuttling protein whereas Acinus is restricted to the nucleus. In MS2 tethering assays Acinus stimulated gene expression at the RNA level, while MLN51, another EJC factor, stimulated mRNA translational efficiency. Using tandem affinity purification (TAP) of proteins overexpressed in HeLa cells, we demonstrated that Acinus binds directly to another EJC component, RNPS1, while stable association of SAP18 to form the trimeric apoptosis and splicing associated protein (ASAP) complex requires both Acinus and RNPS1. Using the same methodology, we further identified what appears to be the minimal stable EJC core, a heterotetrameric complex consisting of eIF4AIII, Magoh, Y14, and MLN51. 相似文献
20.
Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145
下载免费PDF全文
![点击此处可从《Molecular and cellular biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Vpr, the viral protein R of human immunodeficiency virus type 1, induces G(2) cell cycle arrest and apoptosis in mammalian cells via ATR (for "ataxia-telangiectasia-mediated and Rad3-related") checkpoint activation. The expression of Vpr induces the formation of the gamma-histone 2A variant X (H2AX) and breast cancer susceptibility protein 1 (BRCA1) nuclear foci, and a C-terminal domain is required for Vpr-induced ATR activation and its nuclear localization. However, the cellular target of Vpr, as well as the mechanism of G(2) checkpoint activation, was unknown. Here we report that Vpr induces checkpoint activation and G(2) arrest by binding to the CUS1 domain of SAP145 and interfering with the functions of the SAP145 and SAP49 proteins, two subunits of the multimeric splicing factor 3b (SF3b). Vpr interacts with and colocalizes with SAP145 through its C-terminal domain in a speckled distribution. The depletion of either SAP145 or SAP49 leads to checkpoint-mediated G(2) cell cycle arrest through the induction of nuclear foci containing gamma-H2AX and BRCA1. In addition, the expression of Vpr excludes SAP49 from the nuclear speckles and inhibits the formation of the SAP145-SAP49 complex. To conclude, these results point out the unexpected roles of the SAP145-SAP49 splicing factors in cell cycle progression and suggest that cellular expression of Vpr induces checkpoint activation and G(2) arrest by interfering with the function of SAP145-SAP49 complex in host cells. 相似文献